Advances in Idiopathic Inflammatory Myopathies Classification: Paving the Way for Personalized Management

참고문헌 (7)

1. Bohan A, "Polymyositis and dermatomyositis(first of two parts)", N Engl J Med, 292, pp.344~347 (1975)
2. Bohan A, "Polymyositis and dermatomyositis(second of two parts)", N Engl J Med, 292, pp.403~407 (1975)
3. Casal-Dominguez M, "Performance of the 2017 European Alliance of Associations for Rheumatology", American College of Rheumatology classification criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies, 2022, pp.74, 508~517
4. Mariampillai K, "Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies", JAMA Neurol, 75, pp.1528~1537 (2018)
5. Kang M, "Statin-induced immune-mediated necrotizing myopathy does not always present with immediate or severe symptoms", J Clin Neurol, 18, pp.489~491 (2022)
6. Park YE, "Clinicopathological reclassification of idiopathic inflammatory myopathy to match the serological results of myositis-specific antibodies", J Clin Neurol, 20, pp.67~77 (2024)
7. Oh EK, "Clinical and radiological features of Korean patients with anti-HMGCR myopathy", J Clin Neurol, 19, pp.460~468 (2023)

관련 논문AI추천